tiprankstipranks
Sangamo Biosciences (SGMO)
NASDAQ:SGMO
US Market

Sangamo Biosciences (SGMO) Income Statement

Compare
2,238 Followers

Sangamo Biosciences Income Statement

Last quarter (Q3 2024), Sangamo Biosciences's total revenue was $49.41M, an increase of 425.77% from the same quarter last year. In Q3, Sangamo Biosciences's net income was $10.67M. See Sangamo Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 176.23M$ 111.30M$ 110.70M$ 118.19M$ 102.43M
Gross Profit
$ -45.33M$ 99.19M$ 101.26M$ -62.45M$ -43.49M
Operating Expenses
$ 450.24M$ 312.58M$ 294.04M$ 247.74M$ 207.61M
Depreciation and Amortization
$ 22.19M$ 12.11M$ 9.44M$ 5.68M$ 3.93M
EBITDA
$ -87.43M$ -189.17M$ -173.90M$ -123.87M$ -101.25M
Operating Income
$ -274.00M$ -201.28M$ -183.34M$ -129.55M$ -105.18M
Other Income/Expenses
$ 11.10M$ 9.43M$ 5.35M$ 8.78M$ 9.76M
Pretax Income
$ -262.90M$ -191.85M$ -177.99M$ -120.78M$ -95.42M
Net Income
$ -257.83M$ -192.28M$ -178.30M$ -121.12M$ -75.82M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.48$ -1.25$ -1.23$ -0.90$ -0.68
Diluted EPS
$ -1.48$ -1.25$ -1.23$ -0.90$ -0.68
Weighted Average Shares Outstanding
174.44M 154.34M 144.57M 134.45M 112.11M
Weighted Average Shares Outstanding (Diluted)
174.44M 154.34M 144.57M 134.45M 112.11M
Currency in USD

Sangamo Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis